| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 06/07/2006 | CN1784419A Streptococcus agalactiae antigens i + ii |
| 06/07/2006 | CN1782708A Use of Dayan peptide/inflammation factor/in preparing tag diagnosing mammary cancer |
| 06/07/2006 | CN1782078A Heavy Chain and light chain variable area gene of mouse antihuman lipopolysaccharide acceptor antibody and its use |
| 06/07/2006 | CN1782077A HAb18Gedomab 1 monoclonal antibody and its light and heavy chain variable area genes, coding polypeptide and use |
| 06/07/2006 | CN1782072A Vector |
| 06/07/2006 | CN1781947A Modified peptides as therapeutic agents |
| 06/07/2006 | CN1781946A Modified peptides as therapeutic agents |
| 06/07/2006 | CN1781945A Modified peptides as therapeutic agents |
| 06/07/2006 | CN1781944A Sperm protein monoclonal antibody and its preparing method and use |
| 06/07/2006 | CN1258539C Compositions and methods for generating monoclonal antibodies representative of a specific cell type |
| 06/07/2006 | CN1258521C Method for preparing 2 methyl 4 chlorine artificial half antigen, artificial antigen, specific antibody and application |
| 06/06/2006 | US7057028 14273 Receptor, a novel G-protein coupled receptor |
| 06/06/2006 | US7057022 Antibodies which specifically bind to TNF-R |
| 06/06/2006 | US7057021 Nucleotide sequences coding enzymatic polypeptide for use in detection and treatment of cancer |
| 06/06/2006 | US7057018 Pro 1474 polypeptides |
| 06/06/2006 | US7056885 Fibroblast growth factor and nucleic acids encoding same |
| 06/06/2006 | US7056884 Reduced FK228 and use thereof |
| 06/06/2006 | US7056882 Treatment to prevent loss of and/or increase bone mass in metabolic bone diseases |
| 06/06/2006 | US7056735 Mimetics and inhibitors of the interaction between Vpr (HIV viral protein of regulation) and ANT (Mitochondrial adenine nucleotide translocator) |
| 06/06/2006 | US7056720 LLG polypeptides of the triacylglycerol lipase family, and compositions and methods for their use in enzymatic hydrolysis, and protein and gene therapies |
| 06/06/2006 | US7056702 Immunoglobulin for detecting inflammation and bacterial infections in mammals |
| 06/06/2006 | US7056701 Hormone and albumin fusion protein |
| 06/06/2006 | US7056692 Modulation of pleiotrophin signaling by receptor-type protein tyrosine phosphatase beta/zeta |
| 06/06/2006 | US7056681 For modulating cytokine, interferon, and tumor necrosis factor levels |
| 06/06/2006 | US7056680 Antibody binding; gene therapy; genetic mapping |
| 06/06/2006 | US7056677 Soluble mast cell function associated antigen (MAFA) pharmaceutical compositions and methods of making and using them |
| 06/06/2006 | US7056666 Labeling a terminal monomer and scanning to determine the position; can analyze hundreds of macromolecules simultaneously |
| 06/06/2006 | US7056519 Methods for inducing HIV-neutralizing antibodies |
| 06/06/2006 | US7056518 Malarial pre-erythrocytic stage polypeptide molecules |
| 06/06/2006 | US7056517 Glucosyltransferase immunogens |
| 06/06/2006 | US7056516 Comprises nucleotide sequences coding caspase 8 inhibitory protein for use in the treatment of alzheimer's, parkinson's, arthritic, septic, cardiovascular, inflammatory, osteoporotic and ischemic reperfusion injuries/disorders |
| 06/06/2006 | US7056510 Streptococcus pneumoniae SP036 polynucleotides, polypeptides, antigens and vaccines |
| 06/06/2006 | US7056509 Monoclonal antibodies used as antagonists vascular endothelial growth factors (VEGF); angiogenesis inhibitors; antitumor agents |
| 06/06/2006 | US7056508 Receptor-type phosphotyrosine phosphatase-kappa antibodies |
| 06/06/2006 | US7056506 Methods for detecting and inhibiting angiogenesis |
| 06/06/2006 | US7056505 Antibody for use in the diagnosis, prevention and treatment of infections, autoimmune disorders, arthritis, graft rejection and graft-versus-host disease |
| 06/06/2006 | CA2363493C Attenuated forms of bovine viral diarrhea virus |
| 06/06/2006 | CA2120153C Recombinant immunotoxins |
| 06/06/2006 | CA1341506C Factor viii coagulant polypeptides and monoclonal antibodies to them |
| 06/01/2006 | WO2006058300A2 Antibodies and peptide antigens for producing antibodies having a selective binding specificity to bioactive intact parathyroid hormone (pth) 1-84 |
| 06/01/2006 | WO2006057623A1 Runx3 antibodies and method of obtaining the antibodies |
| 06/01/2006 | WO2006057454A1 A method of prime-boost vaccination |
| 06/01/2006 | WO2006057339A1 Method of producing antibody |
| 06/01/2006 | WO2006057217A1 Dfrp proteins regulating drg proteins and utilization of the same |
| 06/01/2006 | WO2006057027A1 Antigenic epitopes of interleukin-21, related antibodies and their use in medical field |
| 06/01/2006 | WO2006057009A1 Highly specific polyclonal antibodies of individual core histone and uses thereof |
| 06/01/2006 | WO2006056779A2 ANTI-TNF ALPHA ANTIBODIES WHICH SELECTIVELY INHIBIT TNF ALPHA SIGNALLING THROUGH THE p55R |
| 06/01/2006 | WO2006056479A1 Sly1 inhibitors in transplantation |
| 06/01/2006 | WO2006056259A1 Treatment of neurodegenerative diseases by the use of laptm4a |
| 06/01/2006 | WO2006056245A1 Use of a human chitinase-like protein in diagnosis and therapy |
| 06/01/2006 | WO2006056031A1 Use of ferrous ions for increasing the immunoreactivity of immunoglobulin preparations |
| 06/01/2006 | WO2006017174A3 Antibodies against cancer produced using masked cancer cells as immunogen |
| 06/01/2006 | WO2006008548A3 Binding molecules |
| 06/01/2006 | WO2005123779A3 Antibodies binding to cd34+/cd36+ fetal but not to adult cells |
| 06/01/2006 | WO2005121178A3 Immunoaffinity chromatography polyol-responsive monoclonal antibodies |
| 06/01/2006 | WO2005117976A3 Method of increasing radiation sensitivity by inhibition of beta one integrin |
| 06/01/2006 | WO2005117975A3 Methods for treating vascular disease |
| 06/01/2006 | WO2005115458A9 Methods and compositions related to regulation of nucleo-cytoplasmic localization of e1 dna helicase in papillomaviruses |
| 06/01/2006 | WO2005108989A3 Assay for antibodies |
| 06/01/2006 | WO2005103243A3 Carboxypeptidases b from anopheles gambiae. compositions comprising them, vaccine applications and use as therapeutical targets |
| 06/01/2006 | WO2005095582A3 Novel cell culture medium supplements |
| 06/01/2006 | WO2005094356A3 Cngh0011 polynucleotides, polypeptides, antibodies, and compositions, and methods of production and use |
| 06/01/2006 | WO2005087915A3 Use of ethanolamine for enhancing cell growth in membrane systems |
| 06/01/2006 | WO2005063299A3 Compositions and methods for the treatment of tumor of hematopoietic origin |
| 06/01/2006 | WO2005047478A3 Compositions and methods for regulation of tumor necrosis factor-alpha |
| 06/01/2006 | WO2005037866A8 Igg3 anti rhesus-d in the line yb2/0 having a high phagocytosis activity |
| 06/01/2006 | WO2005001025A3 Immunoglobulin chimeric monomer-dimer hybrids |
| 06/01/2006 | WO2004096122A3 Use of ngf antagonists and opioids for treating pain |
| 06/01/2006 | WO2003025542A3 Immune response associated proteins |
| 06/01/2006 | WO2002099069A3 Modulating neuronal outgrowth via the major histocompatibility complex class i (mhc i) molecule |
| 06/01/2006 | US20060116507 Osteogenic devices |
| 06/01/2006 | US20060116506 Tenebrio antifreeze proteins |
| 06/01/2006 | US20060116317 Dyeing keratin material; using ninhydrin material |
| 06/01/2006 | US20060115897 Compositions and methods modulating variola and vaccinia virus |
| 06/01/2006 | US20060115875 Characterizing hepatitis C viral infection by determining a similarity between a viral sequence of an hypervariable region 1 (HVR1) of the second envelope protein (E2) region of an hepatitis C virus that infected the host and a variable region kappa light chain of an immunoglobulin of the host |
| 06/01/2006 | US20060115867 TRIM 5 related protein as a biomarker of neurodegenerative disease |
| 06/01/2006 | US20060115859 Tyrosylprotein sulfotransferases and methods of use thereof |
| 06/01/2006 | US20060115856 2'-5'-oligoadenylate synthetase like protein as a biomarker for neurodegenerative disease |
| 06/01/2006 | US20060115855 FK506-binding protein 7 related protein as a biomarker for neurodegenerative disease |
| 06/01/2006 | US20060115854 Acetyl-LDL receptor related proteins and peptides as a biomarker for neurodegenerative disease |
| 06/01/2006 | US20060115813 Intracellular signaling molecules |
| 06/01/2006 | US20060115490 vaccines, immunogenic compositions; diagnostics, enzymatic studies and targets for antibiotics; for treating Staphylococcus aureus infection |
| 06/01/2006 | US20060115486 Staphylococcal PNAG/dPNAG-binding complementarity determining regions (CDR); for diagnosis and treatment of Staphylococcal and other PNAG-expressing bacterial infections |
| 06/01/2006 | US20060115484 Nucleic acid for modulating apoptosis |
| 06/01/2006 | US20060115483 Receptor polypeptide and polynucleotide encoding polypeptide; anticancer agents; viricides; multiple sclerosis; antiarthritic agents; cardiovascular disorders; osteoporosis |
| 06/01/2006 | US20060115480 Disease treatment via antimicrobial peptide inhibitors |
| 06/01/2006 | US20060115478 Compositions and methods for treating and preventing type-1 diabetes |
| 06/01/2006 | US20060115477 Neuropilin-1 inhibitors |
| 06/01/2006 | US20060115476 Antibodies anti-c5 component of the complement system and their use |
| 06/01/2006 | US20060115475 Toll like receptor 3 antagonists, methods and uses |
| 06/01/2006 | US20060115470 Camelidae antibodies against imminoglobulin e and use thereof for the treatment of allergic disorders |
| 06/01/2006 | US20060115451 Modified cytokines for use in cancer therapy |
| 06/01/2006 | US20060115428 Identification and characterization of function-blocking anti-ED-B-fibronectin antibodies |
| 06/01/2006 | CA2630475A1 Mer diagnostic and therapeutic agents |
| 06/01/2006 | CA2589487A1 Means and methods for detecting methylated dna |
| 06/01/2006 | CA2589471A1 Antibodies and peptide antigens for producing antibodies having a selective binding specificity to bioactive intact parathyroid hormone (pth) 1-84 |
| 06/01/2006 | CA2587889A1 Antigenic epitopes of interleukin-21, related antibodies and their use in medical field |
| 06/01/2006 | CA2587775A1 Plasmin-inhibitory therapies |
| 05/31/2006 | EP1662007A1 Preventive or remedy for inflammatory bowel diseases containing anti-cd81 antibody as the active ingredient |
| 05/31/2006 | EP1661998A2 Antigenic polypeptides, antibodies binding thereto, nucleic acids encoding the antigens, and methods of use |